Growth Metrics

Eli Lilly (LLY) Revenue Growth (5y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 23.81%
Dec 31, 2025 20.99%
Sep 30, 2025 25.12%
Jun 30, 2025 23.12%
Mar 31, 2025 16.78%
Dec 31, 2024 17.22%
Sep 30, 2024 15.87%
Jun 30, 2024 14.93%
Mar 31, 2024 11.48%
Dec 31, 2023 10.66%
Sep 30, 2023 12.35%
Jun 30, 2023 8.28%
Mar 31, 2023 6.99%
Dec 31, 2022 3.46%
Sep 30, 2022 4.17%
Jun 30, 2022 2.18%
Mar 31, 2022 8.36%
Dec 31, 2021 6.79%
Sep 30, 2021 5.46%
Jun 30, 2021 4.51%
Mar 31, 2021 6.94%
Dec 31, 2020 6.72%
Sep 30, 2020 2.97%
Jun 30, 2020 2.01%
Mar 31, 2020 4.76%
Dec 31, 2019 3.61%
Sep 30, 2019 2.35%
Jun 30, 2019 2.69%
Mar 31, 2019 1.69%
Dec 31, 2018 -0.60%
Sep 30, 2018 -1.67%
Jun 30, 2018 -1.19%
Mar 31, 2018 -2.39%
Dec 31, 2017 0.67%
Sep 30, 2017 0.78%
Jun 30, 2017 0.79%
Mar 31, 2017 -1.37%
Dec 31, 2016 -0.96%
Sep 30, 2016 -3.32%
Jun 30, 2016 -2.87%
Mar 31, 2016 -3.58%
Dec 31, 2015 -2.77%
Sep 30, 2015 -2.00%
Jun 30, 2015 -2.29%
Mar 31, 2015 -3.27%
Dec 31, 2014 -2.90%
Sep 30, 2014 -1.97%
Jun 30, 2014 -1.39%
Mar 31, 2014 -1.49%